Diagnostic antibodies and antigens for multiple animal disease testing
Click the button of Pathogen/Target Name to search:
Animal disease outbreaks have been shown to cause major economic losses over the centuries. Several diseases such as walking pneumonia, anaplasmosis, aspergilloma, athlete's foot, babesiosis, bacteremia, brucellosis, campylobacteriosis, candidemia, candidiasis, cellulitis, cholangitis, cholecystitis, clostridial enterotoxicosis, clostridiosis, colitis, cryptosporidiosis, dermatophytosis, diarrhoea, endocarditis, epizootic hemorrhagic disease, esophagitis, foot and mouth disease, fungal infection of nail, jock itch, and ringworm, fungemia, gastroenteritis, giardiasis, hemolytic-uremic syndrome, haemorrhage, hepatitis E, intra-abdominal infection, meningitis, minor skin infections, neonatal meningitis, neosporosis, osteomyelitis, pelvic inflammatory diseases, peritonitis, pneumonia, prostatitis, pulmonary infections, sepsis, septicemia, skin infections, tinea or ringworm, toxic shock syndrome, toxoplasmosis, traveler's diarrhea, trichinosis, tuberculosis, typhoid, urinary and septic infections, west nile fever, wound infection and so on affect multiple animals. An early detection system enables the timely detection and identification of an incursion or emergence/re-emergence of a disease/infection in a given country, zone or compartment prevent the disease outbreak. The exquisite specificity of antigen-antibody interactions has led to the development of a variety of immunologic assays, which can be used to detect the presence of either antibody or antigen. Genemedi developed the antigen and antibody to detect the animal diseases. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Veterinary diagnostic metabolite biomarkers are specific molecules found in biological samples of animals that are indicative of a particular disease or condition. The identification and measurement of these biomarkers through metabolomics analysis provide important information for veterinarians to diagnose the disease and monitor its progression. These metabolites serve as the molecular fingerprints of the physiological state of the animal and can be used as biomarkers for disease diagnosis. The discovery of veterinary diagnostic metabolite biomarkers has great potential in clinical veterinary medicine. These biomarkers can be used for early detection, accurate diagnosis, and monitoring of the progression of diseases in animals, including cancer, diabetes, liver disease, and other metabolic disorders. As a result, metabolomics analysis is becoming increasingly important in veterinary medicine and holds promise for improving animal health. GeneMedi offers paired antibodies (monoclonal antibody, mab) and antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for VT-metabolite Biomarker rapid test kit in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immunoassay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.